Emergency Echocardiography in Sepsis
GENESIS
Impact of Early Haemodynamic Assessment by Echocardiography on Organ Dysfunction of Patients Admitted in the Emergency Department for Sepsis or Septic Shock
1 other identifier
interventional
312
1 country
10
Brief Summary
Acute circulatory failure that combines hypovolemia, vasoplegia and cardiac dysfunction plays a major role in the development of sepsis-related organ dysfunction. Pathophysiological mechanisms are multiple and complex. The objective of the GENESIS study is to determine the impact of early haemodynamic assessment using echocardiography in association with a therapeutic algorithm (intervention arm), when compared with standard of care based on the current Surviving Sepsis Campaign (SSC) recommendations (control arm), on the development of organ dysfunctions in patients admitted to the Emergency Department for sepsis or septic shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable sepsis
Started Jul 2021
Longer than P75 for not_applicable sepsis
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2020
CompletedFirst Posted
Study publicly available on registry
October 9, 2020
CompletedStudy Start
First participant enrolled
July 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2025
CompletedNovember 21, 2025
November 1, 2025
3.7 years
September 28, 2020
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Sequential Organ Failure Assessment (SOFA) score
Crude variation of the SOFA score between inclusion and 24h following randomization.
change from Hour 0 at Day 1
Secondary Outcomes (20)
Interruption of fluid resuscitation
Hour 3
Maintains of fluid resuscitation
Hour 3
Initiation of inotropes
Hour 3
Initiation of vasopressor support
Hour 3
Therapeutic modification
Hour 3
- +15 more secondary outcomes
Study Arms (2)
Intervention arm
EXPERIMENTALAssessment using an early transthoracic echocardiography (after 500 mL of fluids) to identify the hemodynamic profile responsible for the acute circulatory failure associated with sepsis / septic shock and to guide ongoing treatment (therapeutic algorithm) and monitor its efficacy and tolerance.
Control arm
OTHERConventional management according to current standards of care based on SSC recommendations, including a standardized fluid resuscitation of 30 mL/kg.
Interventions
In the intervention arm, echocardiography will be performed immediately and potentially repeated to confirm the need for additional fluid resuscitation up to 30 mL/kg in the presence of persisting hypovolemia, or not (e.g., severe ventricular dysfunction). A therapeutic algorithm will allow standardized impact on ongoing management according to the hemodynamic profile identified by early echocardiography. After the completion of initial fluid resuscitation up to 30 mL/kg if required, a new echocardiographic assessment will be systematically performed by the same operator to stop or not fluid resuscitation, and to potentially initiate another treatment according to both the hemodynamic profile and clinical context.
In the control arm, patients will be treated according to standards of care based on current SSC recommendations, including a fluid resuscitation of 30 mL/kg.
Eligibility Criteria
You may qualify if:
- Patients admitted to the ED
- Age ≥ 18 years and affiliation to Social Security
- With sepsis (Sepsis-3 definition):
- Clinically suspected or documented acute infection
- AND a quick score Sequential Organ Failure Assessment (qSOFA) ≥ 2 points with:
- Systolic blood pressure ≤ 100 mmHg (1 point) requiring fluid loading
- AND encephalopathy (1 point) OR respiratory rate ≥ 22 cpm (1 point) AND a systolic blood pressure ≤ 100 mmHg after 500 mL of crystalloid vascular filling - Informed consent
You may not qualify if:
- Decision to limit care or moribund status
- Pregnancy or breast feeding
- Subject under juridical protection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
CH d'Albi
Albi, 81000, France
CH d'Eaubonne - Montmorency
Eaubonne, 95600, France
Grenoble university hospital
La Tronche, 38700, France
Limgoes university hospital
Limoges, 87042, France
Hospices civils de Lyon
Lyon, 69003, France
Nantes university hospital
Nantes, 44093, France
Nice university hospital
Nice, 06600, France
Poitiers university hospital
Poitiers, 86000, France
La réunion university hospital
Saint-Pierre, 97410, France
Toulouse university hospital
Toulouse, 31059, France
Related Publications (1)
Lafon T, Le Gouge A, Brit S, Giraudeau B, Vignon P. Impact of early haemodynamic assessment by echocardiography on organ dysfunction and outcome of patients admitted to the emergency department with sepsis or septic shock: protocol of a multicentre randomised controlled trial (GENESIS). BMJ Open. 2025 May 6;15(5):e098304. doi: 10.1136/bmjopen-2024-098304.
PMID: 40335132DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2020
First Posted
October 9, 2020
Study Start
July 23, 2021
Primary Completion
April 8, 2025
Study Completion
April 15, 2025
Last Updated
November 21, 2025
Record last verified: 2025-11